Norwegian Study on District Treatment of ST-Elevation Myocardial Infarction
Benefits and Costs in Two Different Strategies for Treating Acute Myocardial Infarction With ST-Elevation.
2 other identifiers
interventional
266
1 country
1
Brief Summary
In the district areas of Norway patients with acute myocardial infarction with ST-elevation, are treated with thrombolysis. An increasing part of them receives thrombolysis before arrival to the local hospital.Usually these patients have been sent to an invasive center if thrombolysis fails or the patient gets ischemic symptoms during the stay. This study will compare this strategy against immediate transportation to an invasive center after the patient has received thrombolysis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Feb 2005
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2005
CompletedFirst Submitted
Initial submission to the registry
September 9, 2005
CompletedFirst Posted
Study publicly available on registry
September 12, 2005
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2009
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2009
CompletedApril 17, 2009
April 1, 2009
4.3 years
September 9, 2005
April 16, 2009
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Death , myocardial infarction ,stroke or ischemia during 12 months.
12 months
Costs during 12 months.
12 months
Secondary Outcomes (2)
Size of infarction.
3 months
Complications
1 month
Interventions
Immediate transport to invasive center after thrombolysis
Eligibility Criteria
You may qualify if:
- Duration of painless than 6 hours.
- ST-segment elevation of at least 0.1 mV in two or more extremity leads or at least 0.2 mV in two or more precordial leads.
- The patient is getting thrombolysis.
- Time to reach an invasive center is more than 1 hour.
- Age 18-75 years.
You may not qualify if:
- Known serious renal failure (creatinin \> 250 mmol/l)
- Pregnancy
- Cardiogenic chock
- Life threatening arrythmias
- Other serious diseases with life expectancy less than 1 year.
- Inability to perform an informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Ullevaal University Hospitallead
- Helse Innlandetcollaborator
Study Sites (1)
Ulleval University Hospital
Oslo, 0407, Norway
Related Publications (6)
Bohmer E, Kristiansen IS, Arnesen H, Halvorsen S. Health-related quality of life after myocardial infarction, does choice of method make a difference? Scand Cardiovasc J. 2014 Aug;48(4):216-22. doi: 10.3109/14017431.2014.923581. Epub 2014 Jun 26.
PMID: 24828790DERIVEDHalvorsen S, Seljeflot I, Weiss T, Bohmer E, Arnesen H. Inflammatory and thrombotic markers in patients with ST-elevation myocardial infarction treated with thrombolysis and early PCI: a NORDISTEMI substudy. Thromb Res. 2012 Sep;130(3):495-500. doi: 10.1016/j.thromres.2012.04.016. Epub 2012 May 17.
PMID: 22607887DERIVEDBohmer E, Kristiansen IS, Arnesen H, Halvorsen S. Health and cost consequences of early versus late invasive strategy after thrombolysis for acute myocardial infarction. Eur J Cardiovasc Prev Rehabil. 2011 Oct;18(5):717-23. doi: 10.1177/1741826711398425. Epub 2011 Feb 18.
PMID: 21450598DERIVEDMistry N, Bohmer E, Hoffmann P, Muller C, Bjornerheim R, Kjeldsen SE, Halvorsen S. Left ventricular function in acute myocardial infarction treated with thrombolysis followed by early versus late invasive strategy. Am Heart J. 2010 Jul;160(1):73-9. doi: 10.1016/j.ahj.2010.04.011.
PMID: 20598975DERIVEDBohmer E, Hoffmann P, Abdelnoor M, Arnesen H, Halvorsen S. Efficacy and safety of immediate angioplasty versus ischemia-guided management after thrombolysis in acute myocardial infarction in areas with very long transfer distances results of the NORDISTEMI (NORwegian study on DIstrict treatment of ST-elevation myocardial infarction). J Am Coll Cardiol. 2010 Jan 12;55(2):102-10. doi: 10.1016/j.jacc.2009.08.007. Epub 2009 Sep 10.
PMID: 19747792DERIVEDBohmer E, Arnesen H, Abdelnoor M, Mangschau A, Hoffmann P, Halvorsen S. The NORwegian study on DIstrict treatment of ST-elevation myocardial infarction (NORDISTEMI). Scand Cardiovasc J. 2007 Jan;41(1):32-8. doi: 10.1080/14017430601153472.
PMID: 17365975DERIVED
Study Officials
- PRINCIPAL INVESTIGATOR
Sigrun Halvorsen@uus.no, dr.med
UUS, Oslo, Norway
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
September 9, 2005
First Posted
September 12, 2005
Study Start
February 1, 2005
Primary Completion
June 1, 2009
Study Completion
December 1, 2009
Last Updated
April 17, 2009
Record last verified: 2009-04